{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:02:02Z","timestamp":1791993722273,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ygyno.2025.06.015","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:12:43Z","timestamp":1751371963000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program"],"prefix":"10.1016","volume":"199","author":[{"given":"Oleksandra","family":"Dzyubak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oishika","family":"Tarafdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea N.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Maganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Deljoomanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Laframboise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Q.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pakbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjelica","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Rouzbahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Zad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoun Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.06.015_bb0005","unstructured":"Key Statistics for Endometrial Cancer. How Common Is Uterine Cancer? 2024. Accessed November 12, 2024. https:\/\/www.cancer.org\/cancer\/types\/endometrial-cancer\/about\/key-statistics.html."},{"issue":"10333","key":"10.1016\/j.ygyno.2025.06.015_bb0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2025.06.015_bb0020","series-title":"Cancer of the Endometrium - Cancer Stat Facts","year":"2025"},{"issue":"2","key":"10.1016\/j.ygyno.2025.06.015_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.06.015_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bpobgyn.2008.11.010","article-title":"Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer","volume":"24","author":"Papaioannou","year":"2010","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.06.015_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.soncn.2019.02.002","article-title":"Endometrial Cancer: an overview of pathophysiology, management, and care","volume":"35","author":"Passarello","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"issue":"3","key":"10.1016\/j.ygyno.2025.06.015_bb0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.06.015_bb0045","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","article-title":"European Society of Gynecological Oncology Task Force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients","volume":"25","author":"Rodolakis","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2025.06.015_bb0050","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/cncr.30529","article-title":"Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?","volume":"123","author":"Greenwald","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2025.06.015_bb0055","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.06.015_bb0060","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-0412.2012.01438.x","article-title":"Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey","volume":"91","author":"Lajer","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"5","key":"10.1016\/j.ygyno.2025.06.015_bb0065","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.fertnstert.2012.07.1142","article-title":"Safety of uterine and\/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery","volume":"98","author":"Koskas","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2025.06.015_bb0070","series-title":"NCCN Guidelines. Uterine Neoplasms","author":"Abu-Rustum","year":"2024"},{"issue":"2","key":"10.1016\/j.ygyno.2025.06.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-004047","article-title":"ESGO\/ESHRE\/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2025.06.015_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/OGX.0b013e31822f8f66","article-title":"Fertility-sparing Management of Endometrial Adenocarcinoma","volume":"66","author":"Dorais","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"issue":"2","key":"10.1016\/j.ygyno.2025.06.015_bb0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/medicina59020221","article-title":"Fertility preservation in endometrial cancer\u2014treatment and molecular aspects","volume":"59","author":"Schubert","year":"2023","journal-title":"Medicina"},{"issue":"20","key":"10.1016\/j.ygyno.2025.06.015_bb0090","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.3390\/jcm10204784","article-title":"Fertility-sparing treatment of patients with endometrial cancer: a review of the literature","volume":"10","author":"Leone Roberti Maggiore","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2025.06.015_bb0095","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2019.05.029","article-title":"National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia","volume":"221","author":"Harrison","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.06.015_bb0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing Management in Young Women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.06.015_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer: current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.ygyno.2025.06.015_bb0110","author":"Cancer Care Ontario"},{"issue":"8","key":"10.1016\/j.ygyno.2025.06.015_bb0115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F","article-title":"The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia","volume":"89","author":"Dijkhuizen","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2025.06.015_bb0120","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jogc.2019.03.025","article-title":"Guideline No. 390-classification and Management of Endometrial Hyperplasia","volume":"41","author":"Auclair","year":"2019","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"10","key":"10.1016\/j.ygyno.2025.06.015_bb0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1701-2163(16)32969-3","article-title":"Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia","volume":"30","author":"Giede","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ygyno.2025.06.015_bb0130","first-page":"524","article-title":"Assessing endometrial hyperplasia and carcinoma treated with progestin therapy","volume":"138","author":"Mentrikoski","year":"2012","journal-title":"Anat. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.06.015_bb0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajog.2024.07.018","article-title":"Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis","volume":"231","author":"Suzuki","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.06.015_bb0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1471-0528.2008.02024.x","article-title":"Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases","volume":"116","author":"Signorelli","year":"2009","journal-title":"BJOG"},{"issue":"19","key":"10.1016\/j.ygyno.2025.06.015_bb0145","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.ygyno.2025.06.015_bb0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.06.015_bb0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.06.015_bb0160","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"37","key":"10.1016\/j.ygyno.2025.06.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008034","article-title":"Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.ygyno.2025.06.015_bb0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2025.06.015_bb0175","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e31825dd4ff","article-title":"Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature","volume":"36","author":"Rakha","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.06.015_bb0180","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"issue":"35","key":"10.1016\/j.ygyno.2025.06.015_bb0185","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.ygyno.2025.06.015_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2017.05.002","article-title":"Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer","volume":"146","author":"Park","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.06.015_bb0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/cancers15020485","article-title":"Obesity and cancer: A current overview of epidemiology, pathogenesis, outcomes, and management","volume":"15","author":"Pati","year":"2023","journal-title":"Cancers"},{"issue":"76","key":"10.1016\/j.ygyno.2025.06.015_bb0200","first-page":"215","article-title":"Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer","volume":"14","author":"Carlson","year":"2012","journal-title":"Discov. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2025.06.015_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2025.06.015_bb0210","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/IGC.0000000000000723","article-title":"Oral progestin treatment for early-stage endometrial cancer: a systematic review and meta-analysis","volume":"26","author":"Qin","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2025.06.015_bb0215","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ijgc-00009577-200509000-00041","article-title":"Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection","volume":"15","author":"Mazzon","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2025.06.015_bb0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by Levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"34","key":"10.1016\/j.ygyno.2025.06.015_bb0225","doi-asserted-by":"crossref","first-page":"57642","DOI":"10.18632\/oncotarget.17588","article-title":"Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2025.06.015_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2024.09.015","article-title":"Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment","volume":"191","author":"Jang","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.06.015_bb0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2024.03.017","article-title":"Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia\/endometrial intraepithelial neoplasia \u2013 multicenter retrospective study (KGOG2033)","volume":"183","author":"Kim","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.06.015_bb0240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","article-title":"Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: a systematic review and meta-analysis","volume":"273","author":"De Rocco","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"22","key":"10.1016\/j.ygyno.2025.06.015_bb0245","doi-asserted-by":"crossref","first-page":"12248","DOI":"10.3390\/ijms222212248","article-title":"Fertility sparing treatments in endometrial cancer patients: the potential role of the new molecular classification","volume":"22","author":"Cavaliere","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ygyno.2025.06.015_bb0250","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.ajog.2020.10.003","article-title":"Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer","volume":"224","author":"Chung","year":"2021","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825008820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825008820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:21:11Z","timestamp":1777018871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825008820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":49,"alternative-id":["S0090825825008820"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.06.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}